|Bid||43.38 x 3000|
|Ask||43.68 x 1000|
|Day's Range||43.16 - 45.20|
|52 Week Range||16.74 - 59.25|
|Beta (3Y Monthly)||2.51|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
UK presence positions Spectrum to lead in a key emerging market. SMITHS FALLS, CANADA, OXFORD, UK, TORUŃ, POLAND, Jan. 21, 2019 /CNW/ - Canopy Growth Corporation (TSX:WEED.TO - News) (NYSE:CGC - News) ("Canopy Growth" or the "Company") is pleased to update key European progress in the UK and Poland where its medically-focused business Spectrum Cannabis continues to build a sophisticated, pan-European cannabis production and distribution network serving the needs of physicians and their patients throughout the continent.
Two deals for two big Canadian marijuana producers were announced on the same day, and they hint as to why one of these marijuana stocks is the clear winner.
Ryan McQueeney and Maddy Johnson discuss earnings results from Netflix and the big U.S. banks. The hosts also remember the legacy of Jack Bogle and chat about several new cannabis industry deals.
HENDERSON, NV / ACCESSWIRE / January 18, 2019 / Cannabis remains one of the most volatile and intriguing sectors on the market. Several options in the space remain available at a bargain. One play that ...
Premier Health Group (OTC:PHGRF) (CSE:PHGI), HEXO Corp (OTC PINK: HYYDF), Canopy Growth Corp (CGC) (WEED.TO), and Cronos Group Inc (CRON) are for pot stocks worth keeping tabs on as we close out this week. Premier Health Group (OTC:PHGRF) (CSE:PHGI) has seen impressive gains during the month of January, as the cannabis sector has garnered significant notoriety, as well as a major increase in public support. Earlier this week, Premier Health Group (OTC:PHGRF) (CSE:PHGI) announced that as part of its international expansion strategy, it has entered into a strategic partnership with China'a 360 Health, a healthcare subsidiary of 360 Security Technology.
Canopy Growth Corporation (CGC) closed the most recent trading day at $42.77, moving +1.59% from the previous trading session.
Given that diseases are becoming more difficult to treat, it would seem that we are in desperate need of major advancements in healthcare technology, and many of these steps forward have been made possible through the advent of legalized medical marijuana. Towards the tail-end of last year, Canadian Prime Minister Justin Trudeau and members of the Canadian government agreed to legalize recreational/medicinal cannabis usage, resulting in a rush of energy for Canada's cannabis industry. With the global medical marijuana market predicted to reach $55.0 billion by 2024, according to a new research study published by Global Market Insights, Inc, it stands to reason that companies with the ability to combine the complex medical applications of cannabis with integrative healthcare frameworks could create potential opportunities from entering the nascent marijuana industry.
It’s one of the world’s fastest growing plants—a separate species of the cannabis sativa genus that, due to its 0.3% tetrahydrocannabinol (THC) content, makes it literally almost impossible to get high from smoking it. Just weeks ago, U.S. President Trump signed the 2018 Farm Bill into law. The newly revamped bill legalizes industrial hemp in the U.S., and in doing so not only makes hemp and CBD eligible for lucrative federal crop insurance, but also removes CBD from the Controlled Substances Act.
Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (RIV.V) today announced that Narbe Alexandrian has been appointed as President of the Company, effective immediately. In this role, Narbe will lead the corporate development initiatives as well as manage the day-to-day business of the Company. “I believe that the team at Canopy Rivers has developed one of the most attractive and compelling platforms in the cannabis industry today,” said Narbe Alexandrian, newly appointed President of Canopy Rivers.
The marijuana tailwind has been great for the entire sector, but the most well-known companies got there for a reason. It hasn't received the same level of attention, but the neurology sector is seeing a similar tailwind. This is an immense $6 billion market opportunity in the coming years, and these companies are commanding big market valuations as a result.
Ryan McQueeney covers the latest Brexit news and Snap's executive exodus. He also recaps earnings results from Goldman Sachs, Bank of America, and United Air Lines. Later, he discusses a busy week for deals in the cannabis industry.
CORAL GABLES, FL / ACCESSWIRE / January 16,2019 / Marijuana stocks have been anything but safe over the course of the past year to two years, during the course of which top players in the cannabis industry saw huge boosts in investor interest. With the new year in full swing, Leafbuyer Technologies Inc (LBUY), New Age Beverages Corp (NBEV), Canopy Growth Corp (CGC) (WEED.TO), and Tilray Inc (TLRY) are 4 pot stocks that could make moves on Wednesday. The Company has been referred to as the "Priceline of Pot" by several sources, and similarly to the site which provides travel deals, Leafbuyer is the most comprehensive online source for cannabis deals and specials.
The New York State has granted Canopy Growth Corp. (NYSE: CGC) a license to process and produce hemp. The company plans to invest between $100 million and $150 to establish a hemp industrial park somewhere in the state. Canopy is happy with the current New York political leadership that supports the cannabis business. Canopy Co-CEO […] The post Canopy Growth (NYSE: CGC) to Build $100-150 Hemp Plant in New York appeared first on Market Exclusive.
Cannabis News Cannabis producer FoliuMed has completed the construction of its first greenhouses on a 16-hectare grow site near Bogota, Colombia. In an area spanning 20 soccer fields, FoliuMed will produce over 70 tons of medicinal hemp and cannabis plants in 150 greenhouses. The plants will be processed into oils and sold as pharma-grade ingredients […] The post Cannabis Stock News Daily Roundup January 16 appeared first on Market Exclusive.
SMITHS FALLS, ON , Jan. 15, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) will release its financial results for the third quarter ...